Coinbase Global has delivered its Q2 numbers, they disappointed enough to send the stock down nearly 9% on the day, and the week's most telling development is what happened next: shorts rebuilt rather than covered, and analysts raced to cut targets while keeping their Buy ratings intact.
The earnings reaction was the week's sharpest data point. The stock fell 8.6% the day after the July 30 print — a harder landing than the prior quarter's 2.8% drop — and is now down 10.2% on the week to $150.73, extending a one-month decline of nearly 9%. That reaction matters because the pre-earnings note flagged a bullish tilt in options and a short-covering trend: both of those tailwinds have now reversed. Short interest climbed 7.6% on the week to 11.1% of free float, roughly 25.3 million shares — the highest level since late June and a clear rebuild after the low of around 22.3 million touched just before earnings. The direction has changed. This is no longer pre-earnings hedging that can unwind cleanly; shorts added into weakness after the print. One positive note on the borrow side: cost to borrow has eased to just 0.37%, its lowest reading in the 30-day window, and availability remains a loose 347% of short interest. With roughly 3.5 shares available to lend for every one already borrowed, there is no mechanical squeeze pressure. The short rebuild looks like a judgment call, not a forced position.
Options positioning has pivoted sharply since the prior note. The put/call ratio has dropped to 0.66, more than one standard deviation below its 20-day average of 0.76 and close to the 52-week low of 0.61 in defensiveness. That sounds bullish on its surface — fewer puts relative to calls — but the context matters. The reading was at 0.88 just three weeks ago, when it hit its 52-week high. The post-earnings drop in the PCR likely reflects call-side unwinding rather than fresh bullish conviction; traders who held upside into the print are rolling out. The z-score of -1.17 confirms the PCR is running well below recent norms without being a clean directional signal on its own.
The Street's response to Q2 was a near-universal round of target cuts with very few rating changes — a pattern that says analysts still believe the long-term story but are marking down near-term assumptions. Goldman Sachs trimmed to $173 from $198, keeping its Buy. Cantor Fitzgerald cut more aggressively, to $184 from $250, while maintaining Overweight. Barclays, the lone bear in the group, nudged its Underweight target down to $95 from $99. Benchmark held a Buy but cut to $230 from $270. The mean Street target is now $195.52, roughly 30% above the current price — a wide gap that reflects genuine disagreement about how quickly crypto trading volumes recover. The bull case centres on Coinbase's expansion into prime brokerage, stablecoins via its developer platform, and data services. The bear case is simpler: revenue is still overwhelmingly tied to trading activity, which is cyclical, volatile, and being competed away. ORTEX factor scores back the bull narrative on one specific metric — EPS surprise ranks in the 97th percentile, meaning the company has a strong history of beating estimates — but EPS momentum over both the 30-day and 90-day windows sits in the bottom 1% of the universe, flagging that forward estimates are moving in the wrong direction right now.
Peers held up better on the week. HOOD closed flat to slightly positive on a weekly basis, up 0.8%. BLSH and BULL each gained roughly 4-5%. That divergence matters: crypto-adjacent equities broadly didn't sell off the way COIN did, which isolates the weakness to the earnings print rather than to a broad sector de-rating.
The next scheduled event is August 6 — another earnings-related entry in the data — so the immediate question is whether the post-print short rebuild stabilises or continues to build as the market digests the revenue trajectory and the growing gap between analyst targets and the actual trading price.
See the live data behind this article on ORTEX.
Open COIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
